Клинико-иммунологическая эффективность включения Гепона и Цитофлавина в комплексное лечение хронического эндометрита
article
OA: closed
CC0
AI-generated summary
This study found that adding Gepon and Cytoflavin to standard treatment improved immune and metabolic disturbances and increased the efficiency of chronic endometritis therapy in women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
38 patients of genesial age with the verified diagnosis a chronic endometritis in a stage of incomplete remission are divided into 2 groups: the control, receiving complex standard treatment including an operative measure concerning sterility and medicamental therapy, and the main where the pharmacotherapy was supplemented with Gepon and Сytoflavinum introduction. In the presurgical period at the systemic and local level rising of level of pro-inflammatory and regulatory cytokines, activation of system of a complement, an imbalance in the maintenance of antiinflammatory cytokines, regulators of system of a complement, various classes of immunoglobulins, decrease of the activity and intensity of a phagocytosis with simultaneous rising of activity the oxygen dependent systems of neutrophils of a peripheral blood is established, activation of free radical oxidation, rising in a contents blood plasma the immunosupressors of metabolites is taped (atcetylgydroperox, a malone dialdehyde, C-reactive protein). Insufficient efficiency of application of complex standard treatment in correction of immune and metabolic disturbances is defined. Use in standard treatment of a chronic endometritis of Gepon and Cytoflavinum allows to increase its efficiency and to improve quality of life of patients.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK